On Saturday, the World Health Organization confirmed that it had done so show suspended of Covaccin Through the United Nations procurement agencies is recommended countries that received the vaccine to take “appropriate” actions.
look at what new Directions for Covid-19 vaccine, developed by the Indian Council of Medical Research (ICMR) and Bharat Biotech based in Hyderabad:
Why did the World Health Organization take this step Currently?
Kovacin, India first local vaccine for Covid-19, he had an emergency use Inclusion (EUL) from the World Health Organization in November last year. This means it met Standards set From the World Health Organization for protection against Corona virus disease. WHO’s EUL is also main condition for Vaccine to be part of supply under the COVAX initiative; And so is the birthplace of licensing way for Biotech Spices to supply Covaxin to UN agencies including through COVAX.
At that time, EUL . was for Covaxin was given, however, the World Health Organization has not screened. inspection of Bharat Biotech Facility was set up between 14 and 22 March on owned by the World Health Organization announced This comment of supply of Covaxin through United Nations procurement agencies and recommended countries that received the vaccine “to take appropriate measures.”
What did the WHO inspection find?
The World Health Organization said that the data available Indicate that Covaxin is effective and there is no safety they. However, it has asked the company to address the shortcomings in good manufacturing practice (GMP). In other words, the World Health Organization asked the Bharat biotech company to upgrade and select changes in own manufacturing facilities for Cofaxine.
What are these promotions?
The facilities used to manufacture Covaxin were not specified designed for Covid-19 vaccine. When the company received the emergency use Commissioned by India’s drug regulator, it has re-used its existing facilities, some of which of that was used for Production of poliovirus vaccine, some for rabies vaccine and some for Japanese encephalitis vaccine.
Sources said the World Health Organization had specifically asked the company to update the facilities for manufacture of Covid-19 vaccine, in This case Covaxin.
Why didn’t the company specifically modernize its facilities for Cofaxine earlier?
Company sources said that when the facility needs to be upgraded for A specific vaccine, it must be completely shut down. As such, when the company operates in active Production, can not be done on a large scale maintenance and upgrade.
Secondly, sources said, during the climax of Pandemic, Procurement and Logistics of new equipment required for Upgrading can take anywhere from 15 to 18 months. “It’s not something you can do buy off Dandruff,” one The source said.
industry of Package of Covaxin takes 120 days from start to finish. Shutdown and upgrade of It was possible to perform the attachment in Loss of Almost 6 months. The company can not be shut down His facility only for upgrade because of The urgent need to vaccinate the population, sources said. Therefore, the company, after assessing the risks, decided to do so start Covaxin . Manufacture in Repurposed facility in In a way that the vaccine is safe, they said.
The company can shut down And upgrade the facilities now?
Yes, this is what you will do. Friday, the company announced temporary slowdown down of Produce of Covaxin across its manufacturing facilities, having completed supply commitments to purchasing agencies and anticipating a decrease in demand. The decision Made due to purchase of It’s time for Covid-19 vaccines down.
Sources in the S said that the company began to close down elbows in Ankleeshwar; one The facility is closed to Indian Immunologicals Limited down; except oneAll facilities in Hyderabad are closed down.
The company will now begin maintenance and raising the level of activities.
How long will the upgrade take place?
The sources said that making an upgrade is a complicated process. “Some of The equipment It must be obtained from local suppliers and some of It must be imported. Once you make a change to the facility, it won’t be that simple just Equipment purchase, installation and start using source said.
Once you upgrade completethe company must acquire new products regulatory Assent for commercial use of Enterprise.
The sources said that the company is waiting for for Detailed report of the World Health Organization, after which the company will start the operation of Corrective and Preventive Actions (CAPA). that’s it set of Procedures or regulations required in Manufacturing, documentation, procedures or systems for correcting nonconformities. a report on The CAPA must be submitted to both the Indian regulator and the World Health Organization.
Audits and approvals part of The regulatory mechanism. Companies do it improvement And go back, “Kappa undertakes and implements,” a source said.
How does it affect the supply of Cofaxine?
Does not affect the display of Cofaxine. In the first placeThe company has not received any requests from United Nations agencies, including the GAVI-COVAX facility, to supply Covaxin.
Secondly, in about 25 countriesCovaxin was given as an emergency use Permission (EUA). In this countriesthe company has already Fulfillment of supply obligations. Sources said that they did not receive any new requests from these people countries.
Once again, the company has also Stocked Vaccines required for vaccinate India drive. Based on on That alone, the company in February took a call to slow down down Produce of Cofaxine. Sources said, however, while the company has announced temporary slowdown down of Covaxin production, has already built antigen bank. If the country needs vaccines, we can turn them into vials in 30 to 40 day schedule and product supply,” a source said.
Has the World Health Organization inspected other companies that manufacture Covid-19 vaccines?
Yes, WHO teams They inspected the manufacturing facilities of Several companies have obtained End User License License (EUL). The sources said that in In some cases, a check was conducted even before the end user license agreement was granted. For some manufacturers, inspections have been carried out on Multiple occasions.
the news | Click to get today best commentators in your inbox
.
